Cargando…

Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema

INTRODUCTION: Diabetic retinopathy is the most common cause of visual loss and blindness in the age group of 20 to 64 years. This study aimed to evaluate the efficacy of oral Losartan adjuvant therapy in combination with intravitreal injection of Bevacizumab in the treatment of diabetic macular edem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghassemi, Fariba, Amini, Abdulrahim, Yasemi, Masoud, Nabavi, Amin, Johari, Mohammadkarim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547354/ https://www.ncbi.nlm.nih.gov/pubmed/33062311 http://dx.doi.org/10.1155/2020/4528491

Ejemplares similares

Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration
por: Farvardin, Mohsen, et al.
Publicado: (2022)

Bacillary Layer Detachment in Diabetic Retinopathy: A Case Report
por: Amini, Abdulrahim, et al.
Publicado: (2023)

Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema
por: Faghihi, Hooshang, et al.
Publicado: (2022)

Effect of peripheral laser photocoagulation retinopexy on macular morphology and optic nerve fiber layer thickness; a prospective case series
por: Johari, Mohammadkarim, et al.
Publicado: (2022)

Clinical sign and symptom of primary vitreoretinal lymphoma short-time after retinal reattachment surgery: a case report
por: Fooladi, Marjan Imani, et al.
Publicado: (2022)

Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection
por: Ghassemi, Fariba, et al.
Publicado: (2017)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S.
Publicado: (2012)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon, Sohee, et al.
Publicado: (2014)

Primary Effects of Intravitreal Bevacizumab in Patients with Diabetic Macular Edema
por: Tareen, Iftikhar-ul-Haq, et al.
Publicado: (2013)

Intravitreal Bevacizumab Alone versus Combined with Macular Photocoagulation in Diabetic Macular Edema
por: Lee, Soo Jeong, et al.
Publicado: (2011)

Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema
por: Lee, Yun Ji, et al.
Publicado: (2019)

Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
por: Marey, Hatem M, et al.
Publicado: (2011)

The efficacy of oral pain relief cocktail during pan-retinal photocoagulation for diabetic retinopathy: a randomized clinical trial
por: Johari, Mohammadkarim, et al.
Publicado: (2023)

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
por: Lim, Laurence S, et al.
Publicado: (2015)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
por: Yalamanchi, Shalini, et al.
Publicado: (2011)

Two year result of intravitreal bevacizumab for diabetic macular edema using treat and extend protocol
por: Sugimoto, Masahiko, et al.
Publicado: (2017)

Effect of Intravitreal Bevacizumab with or without Macular Photocoagulation for Diabetic Macular Edema: A Meta-Analysis
por: Xiao, Kang, et al.
Publicado: (2018)

Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up
por: El Matri, Leila, et al.
Publicado: (2021)

The effect of vitamin D supplementation on the outcome of treatment with bevacizumab in diabetic macular edema: a randomized clinical trial
por: Fekri, Sahba, et al.
Publicado: (2022)

Resolution of macular edema in Coats' disease with intravitreal bevacizumab
por: Entezari, Morteza, et al.
Publicado: (2010)

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
por: Kumar, Atul, et al.
Publicado: (2007)

One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders
por: Salimi, Ali, et al.
Publicado: (2021)

Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence
por: Sędziak-Marcinek, Bogumiła, et al.
Publicado: (2021)

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema
por: Al-Dhibi, Hassan, et al.
Publicado: (2014)

Intravitreal Injection of Bevacizumab to Treat a Macular Edema Caused by Leber's Miliary Aneurysm
por: Takeyama, Masayuki, et al.
Publicado: (2012)

Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema
por: Mushtaq, Bushra, et al.
Publicado: (2014)

Short term effect of intravitreal bevacizumab for diabetic macular edema associated with epiretinal membrane
por: Maryam, Ashraf Khorasani, et al.
Publicado: (2018)

Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema
por: Das, Gopal K., et al.
Publicado: (2018)

Multifocal Electroretinogram in Diabetic Macular Edema; Correlation with Visual Acuity and Optical Coherence Tomography
por: Tehrani, Neda Mazahery, et al.
Publicado: (2015)

Intravitreal Bevacizumab May Increase Diabetic Macular Edema in Eyes with Attached Posterior Vitreous
por: Ozsutcu, Mustafa, et al.
Publicado: (2013)

Posterior sub-tenon’s bevacizumab injection in diabetic macular edema; a pilot study
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2015)

Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
por: Joshi, Lavnish, et al.
Publicado: (2016)

One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab
por: Abouhussein, Mahmoud Alaa, et al.
Publicado: (2021)

How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients
por: Sędziak-Marcinek, Bogumiła, et al.
Publicado: (2021)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Clinical observation of the efficacy of Bevacizumab combined with argon green laser in treating fundus macular edema
por: Shao, Yi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n9ltn5k49heqo6rj4kiflsaott